Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
CA 2584482 C · Owner: Cohen, Joseph · Inventors: Cohen, Joseph; Cabezon Silva, Teresa; Vinals Bassols, Carlota
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel proteins and to their production from the MAGE family. In particular, to a MAGE protein fused to an immunological fusion partner such as Lipoprotein D. Such antigens may be formulated to provide vaccines for the treatment of a range of tumours. Novel methods for purifying MAGE proteins are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 2, 1999 and granted March 27, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 2, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 2, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.